1-5 of 5
Daniel M. Geynisman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer

David Pook, Daniel M. Geynisman, Joan Carles, Filippo de Braud, Anthony M. Joshua, José Luis Pérez-Gracia, Casilda Llácer Pérez, Sang Joon Shin, Bruno Fang, Minal Barve, Marco Maruzzo, Sergio Bracarda, Miso Kim, Yannick Kerloeguen, Jorge Daniel Gallo, Sophia L. Maund, Adam Harris, Kuan-Chieh Huang, Victor Poon, Dhruvitkumar S. Sutaria, Howard Gurney
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (17): 3292–3300.
https://doi.org/10.1158/1078-0432.CCR-22-2585
Published: 01 September 2023
View article titled, A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer
Open the PDF for A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

H. Josh Jang, Galen Hostetter, Alexander W. Macfarlane, Zachary Madaj, Eric A. Ross, Toshinori Hinoue, Justin R. Kulchycki, Ryan S. Burgos, Mahvish Tafseer, R. Katherine Alpaugh, Candice L. Schwebel, Rutika Kokate, Daniel M. Geynisman, Matthew R. Zibelman, Pooja Ghatalia, Peter W. Nichols, Woonbok Chung, Jozef Madzo, Noah M. Hahn, David I. Quinn, Jean-Pierre J. Issa, Michael J. Topper, Stephen B. Baylin, Hui Shen, Kerry S. Campbell, Peter A. Jones, Elizabeth R. Plimack
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (11): 2052–2065.
https://doi.org/10.1158/1078-0432.CCR-22-3642
Published: 01 June 2023
View article titled, A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
Open the PDF for A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract B29: Use of deep sequencing of urinary DNA as a biomarker of residual disease status at the time of radical cystectomy

Phillip H. Abbosh, Uttam Satyal, David Liu, Ilsiya Ibragimova, Lauren Szeto, Benjamin Miron, James Ford, Daniel Parker, Aeen Asgar, Daniel M. Geynisman, R. Katherine Alpaugh, Paul Cairns, Costas D. Lallas, Edouard J. Trabulsi, Jean Hoffman-Censits, Eliezer M. Van Allen, Alexander Kutikov, Elizabeth R. Plimack
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15_Supplement): B29.
https://doi.org/10.1158/1557-3265.BLADDER19-B29
Published: 03 August 2020
View article titled, Abstract B29: Use of deep sequencing of urinary DNA as a biomarker of residual disease status at the time of radical cystectomy
Journal Articles

A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157

Noah M. Hahn, Trinity J. Bivalacqua, Ashley E. Ross, George J. Netto, Alex Baras, Jong Chul Park, Carolyn Chapman, Timothy A. Masterson, Michael O. Koch, Richard Bihrle, Richard S. Foster, Thomas A. Gardner, Liang Cheng, David R. Jones, Kyle McElyea, George E. Sandusky, Timothy Breen, Ziyue Liu, Costantine Albany, Marietta L. Moore, Rhoda L. Loman, Angela Reed, Scott A. Turner, Francine B. De Abreu, Torrey Gallagher, Gregory J. Tsongalis, Elizabeth R. Plimack, Richard E. Greenberg, Daniel M. Geynisman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (12): 3003–3011.
https://doi.org/10.1158/1078-0432.CCR-16-2267
Published: 14 June 2017
View article titled, A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <em>FGFR3</em> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
Open the PDF for A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <em>FGFR3</em> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157 in another window
Includes: Supplementary data
Journal Articles

Plasmalemmal Vesicle Associated Protein-1 Is a Novel Marker Implicated in Brain Tumor Angiogenesis

Eleanor B. Carson-Walter, Jessica Hampton, Eveline Shue, Daniel M. Geynisman, Pramod Kumar Pillai, Ramasri Sathanoori, Stephen L. Madden, Ronald L. Hamilton, Kevin A. Walter
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7643–7650.
https://doi.org/10.1158/1078-0432.CCR-05-1099
Published: 08 November 2005
View article titled, Plasmalemmal Vesicle Associated Protein-1 Is a Novel Marker Implicated in Brain Tumor Angiogenesis
Open the PDF for Plasmalemmal Vesicle Associated Protein-1 Is a Novel Marker Implicated in Brain Tumor Angiogenesis in another window